Martin Shkreli Resigns From Turing Pharmaceuticals Following Arrest
One day after he was arrested on suspicions of security fraud, Martin Shkreli has resigned from his position as CEO of Turing Pharmaceuticals.
At Turing, Shkreli made headlines after he had notoriously jacked up prices of the life-saving drug Daraprim and jacking its price up from $13.50 to $750 per tablet. Ron Tilles, the chairman of Turing’s board of directors, will step in as CEO on an interim basis, according to NBC.
46m
7m
3m
41m
59m
22m
8m
4m
6m
1m
1m
54s
41s
1m
41m
9m
2m
16m
8m
30s
9m
9m
5m
21m
20m
2h 14m
2h 5m
56m
1h 30m
1h 34m
54m
1h 42m
1h 59m
20m
47m
1h 25m
1h 25m
2h 3m
1h 36m
8m
1h 25m
22m
1h 7m
41m
1h 36m
51m
57m
20m
42m
1h 17m
41m
22m
1h 38m
20m
7m
30s